In a previous study, Pfeiffer's team showed that blockade of CD155 resulted in decreased lysis of human hepatoblastoma cells (51), while Baofu's group demonstrated that blocking CD155 could enhance the proliferation of healthy CIK cells (52). Here, PVR is linked to hepatoblastoma.